These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21123524)

  • 21. Serum immunoglobulin G subclass levels and estimated clinical severity caused by possible influenza A (H1N1) pdm 2009 infection.
    Yamamoto T; Mizoguchi Y; Kaneno H; Yamamoto K; Inoue Y; Kawashima H; Kase T; Shimotsuji T
    J Infect Chemother; 2013 Oct; 19(5):833-42. PubMed ID: 23467791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.
    Li ZN; Lin SC; Carney PJ; Li J; Liu F; Lu X; Liu M; Stevens J; Levine M; Katz JM; Hancock K
    Clin Vaccine Immunol; 2014 Aug; 21(8):1054-60. PubMed ID: 24872516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional variation in CD55 increases the severity of 2009 pandemic H1N1 influenza A virus infection.
    Zhou J; To KK; Dong H; Cheng ZS; Lau CC; Poon VK; Fan YH; Song YQ; Tse H; Chan KH; Zheng BJ; Zhao GP; Yuen KY
    J Infect Dis; 2012 Aug; 206(4):495-503. PubMed ID: 22693232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase.
    Couch RB; Atmar RL; Franco LM; Quarles JM; Wells J; Arden N; Niño D; Belmont JW
    J Infect Dis; 2013 Mar; 207(6):974-81. PubMed ID: 23307936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma cytokine levels and cytokine gene polymorphisms in Mexican patients during the influenza pandemic A(H1N1)pdm09.
    Martinez-Ocaña J; Olivo-Diaz A; Salazar-Dominguez T; Reyes-Gordillo J; Tapia-Aquino C; Martínez-Hernández F; Manjarrez ME; Antonio-Martinez M; Contreras-Molina A; Figueroa-Moreno R; Valdez-Vazquez R; Kawa-Karasik S; Rodríguez-Zulueta P; Flisser A; Maravilla P; Romero-Valdovinos M
    J Clin Virol; 2013 Sep; 58(1):108-13. PubMed ID: 23809475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection.
    Takano T; Tajiri H; Kashiwagi Y; Kimura S; Kawashima H
    Eur J Clin Microbiol Infect Dis; 2011 Jan; 30(1):117-20. PubMed ID: 20820834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.
    Yang P; Zhang L; Shi W; Lu G; Cui S; Peng X; Zhang D; Liu Y; Liang H; Pang X; Wang Q
    Influenza Other Respir Viruses; 2012 Nov; 6(6):381-8. PubMed ID: 22212858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant protein B gene polymorphism is associated with severe influenza.
    To KKW; Zhou J; Song YQ; Hung IFN; Ip WCT; Cheng ZS; Chan ASF; Kao RYT; Wu AKL; Chau S; Luk WK; Ip MSM; Chan KH; Yuen KY
    Chest; 2014 Jun; 145(6):1237-1243. PubMed ID: 24337193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.
    Marcelin G; Bland HM; Negovetich NJ; Sandbulte MR; Ellebedy AH; Webb AD; Griffin YS; DeBeauchamp JL; McElhaney JE; Webby RJ
    J Infect Dis; 2010 Dec; 202(11):1634-8. PubMed ID: 20979454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infection.
    Guo X; Chen Y; Li X; Kong H; Yang S; Ye B; Cui D; Wu W; Li L
    Virol J; 2011 May; 8():215. PubMed ID: 21569236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host adaptive immunity deficiency in severe pandemic influenza.
    Bermejo-Martin JF; Martin-Loeches I; Rello J; Antón A; Almansa R; Xu L; Lopez-Campos G; Pumarola T; Ran L; Ramirez P; Banner D; Ng DC; Socias L; Loza A; Andaluz D; Maravi E; Gómez-Sánchez MJ; Gordón M; Gallegos MC; Fernandez V; Aldunate S; León C; Merino P; Blanco J; Martin-Sanchez F; Rico L; Varillas D; Iglesias V; Marcos MÁ; Gandía F; Bobillo F; Nogueira B; Rojo S; Resino S; Castro C; Ortiz de Lejarazu R; Kelvin D
    Crit Care; 2010; 14(5):R167. PubMed ID: 20840779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
    Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza.
    Almansa R; Anton A; Ramirez P; Martin-Loeches I; Banner D; Pumarola T; Xu L; Blanco J; Ran L; Lopez-Campos G; Martin-Sanchez F; Socias L; Loza A; Andaluz D; Maravi E; Gordón M; Gallegos MC; Fernandez V; León C; Merino P; Marcos MA; Gandía F; Bobillo F; Resino S; Eiros JM; Castro C; Mateo P; Gonzalez-Rivera M; Rello J; de Lejarazu RO; Kelvin DJ; Bermejo-Martin JF
    BMC Infect Dis; 2011 Aug; 11():232. PubMed ID: 21880131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China.
    Yu H; Feng Z; Uyeki TM; Liao Q; Zhou L; Feng L; Ye M; Xiang N; Huai Y; Yuan Y; Jiang H; Zheng Y; Gargiullo P; Peng Z; Feng Y; Zheng J; Xu C; Zhang Y; Shu Y; Gao Z; Yang W; Wang Y
    Clin Infect Dis; 2011 Feb; 52(4):457-65. PubMed ID: 21220768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus.
    Matsumoto Y; Kawamura Y; Nakai H; Sugata K; Yoshikawa A; Ihira M; Ohashi M; Kato T; Yoshikawa T
    Microbiol Immunol; 2012 Sep; 56(9):651-5. PubMed ID: 22734496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross sectional survey of influenza antibodies before and during the 2009 pandemic in Shenzhen, China.
    Wu CL; Lu J; Wang MH; Lv X; Chen Y; Kung HF; Zee B; Cheng XW; He ML
    PLoS One; 2013; 8(1):e53847. PubMed ID: 23382854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response of healthy children to pandemic A/H1N1/2009 influenza virus.
    Esposito S; Daleno C; Tagliabue C; Scala A; Picciolli I; Taroni F; Galeone C; Baldanti F; Principi N
    Virol J; 2011 Dec; 8():563. PubMed ID: 22208497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
    Shibuya M; Aoshi T; Kuroda E; Yoshioka Y
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of pandemic H1N1 2009 influenza virus recombinant hemagglutinin protein-based enzyme-linked immunosorbent assay for serosurveillance.
    Arankalle VA; Virkar RG; Tandale BV; Ingle NB
    Clin Vaccine Immunol; 2010 Sep; 17(9):1481-3. PubMed ID: 20631333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.